Edna R. Gordián

Methylation-Mediated Repression of <i>GADD45α</i> in Prostate Cancer and Its Role as a Potential Therapeutic Target

Kavitha Ramachandran, Gopal Gopisetty, Edna R. Gordián et al. · Cancer Research · 2009 · 78 citations

Medicine, Oncology, Pharmacology +7

Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy

Rakesh Singal, Kavitha Ramachandran, Edna R. Gordián et al. · Clinical Genitourinary Cancer · 2014 · 77 citations

Medicine, Oncology, Urology +16

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease

Isildinha M. Reis, K. Ramachandran, Carl G. Speer et al. · British Journal of Cancer · 2015 · 43 citations · Full text

Medicine, Molecular Biology, Oncology +17

Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease

Edna R. Gordián, Kavitha Ramachandran, Isildinha M. Reis et al. · Cancer Epidemiology Biomarkers & Prevention · 2010 · 32 citations

Medicine, Oncology, Urology +17

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer

Edna R. Gordián, Eric A. Welsh, Nicholas T. Gimbrone et al. · Oncotarget · 2019 · 30 citations · Full text

Medicine, Bioinformatics, Oncology +17